Soman-induced morphological changes: an overview in the non-human primate

Area of Science:

• Neuroscience
• Toxicology
• Pathology

Background:

• Organophosphorus (OP) compounds are potent neurotoxins.
• Soman (pinacolyl methylphosphonofluoridate) is an irreversible acetylcholinesterase inhibitor.
• Non-human primates are used to model OP toxicity.

Purpose of the Study:

• To review literature on organophosphorus-induced morphological changes in non-human primates.
• To examine acute and chronic effects of soman exposure.
• To evaluate the impact of nerve agent therapy on soman-induced lesions.

Main Methods:

• Literature review of studies on organophosphorus compounds in non-human primates.
• Analysis of morphological changes in central nervous system and non-neural tissues.
• Evaluation of soman effects with and without therapeutic interventions.

Main Results:

• Soman exposure caused acute neuronal degeneration, necrosis, and edema in primate brains, particularly in the cortex, amygdala, and hippocampus.
• These lesions resemble those from hypoxic-ischemic injury or seizures.
• Acute cardiac and skeletal muscle lesions were also observed.
• Nerve agent therapy combined with an anticonvulsant reduced or prevented acute neural damage.
• Consistent chronic changes were not observed in rhesus monkeys or baboons.

Conclusions:

• Organophosphorus nerve agents induce significant acute morphological changes in the non-human primate central nervous system and heart.
• Therapeutic interventions, especially with anticonvulsants, can mitigate these acute effects.
• Further research may be needed to understand chronic OP toxicity.